Pharmabiz
 

Lilavati introduces bio-prosthetic heart valve, 'Trifecta Valve' with 20-year life span

Our Bureau, MumbaiTuesday, May 15, 2012, 17:20 Hrs  [IST]

Lilavati Hospital, Mumbai has introduced fourth generation most expensive bio-prosthetic heart valve, “Trifecta Valve” in Mumbai. This new technology is now available in India which can save your heart and can give you an increased life span of 20 years and more.

Bhanumati Lakhani, a 69 years old patient who suffered from aortic heart valve disease, has got latest aortic valve replacement heart surgery. This surgery was performed by senior heart surgeon, Dr Pavan Kumar recently at Lilavati Hospital.

Dr Pavan Kumar informed, “It is the most refined fourth generation bio-prosthesis called “Trifecta Valve” presently available among all tissue valves. With price tag of Rs.2,50,000/- per piece, it is expensive but has latest technology incorporated in designing and manufacturing thus providing long lasting durability of 20 years and beyond as claimed by manufacturers.” He further adds, “This fourth generation prosthesis is probably best for heart patients. The latest trend is towards the use of biological (Tissue Heart Valve) valve similar to western world now, as patients demand drug free post-operative period.”

Trifecta Valve was introduced in India in February 2012 after two years of over 12,000 implantations all over world. It is pericardial tissue valve placed on Titenum housing with latest Linx Technique anti-calcification treatment for longer durability, providing best haemodynamic even in smallest size among all tissue heart valves.

With introduction of this valve, patients of heart valve disease specially beyond their fifties and ladies in child bearing age,will have tremendous relief now. This Trifecta Valve eliminates anticoagulation treatment after implantation. This removes all side effects and consequent complications of anticoagulation treatment in long term for patients with mechanical heart valve prosthesis.

Facts suggest that presently among all heart diseases 35% to 40% patients suffer from heart valve disease. This is mainly due to post Rheumatic infection in childhood or by birth malformations in valves. In elderly patients this can be degenerative disease of valve. In India, more than 1,50,000 patients undergo heart valve operations of repair and replacement every year. This is usually considered as safe heart operation with mortality of less than 4% in experienced surgeons and good centres.

Artificial prosthetic heart valves are of two varieties- mechanical- made of metal with carbon coating and tissue (Biological) - these are usually imported and cost from 50,000/- per piece upwards.

This latest generation most expensive bio-prosthetic heart valve is available only for Aortic Heart valve disease.

 
[Close]